A detailed history of Covestor LTD transactions in Alector, Inc. stock. As of the latest transaction made, Covestor LTD holds 14 shares of ALEC stock, worth $35. This represents 0.0% of its overall portfolio holdings.

Number of Shares
14
Previous 15 6.67%
Holding current value
$35
Previous $0 NaN%
% of portfolio
0.0%
Previous 0.0%

Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

SELL
$4.34 - $6.58 $4 - $6
-1 Reduced 6.67%
14 $0
Q1 2024

May 10, 2024

BUY
$5.69 - $8.08 $34 - $48
6 Added 66.67%
15 $0
Q4 2023

Feb 09, 2024

SELL
$3.77 - $8.39 $3 - $8
-1 Reduced 10.0%
9 $0
Q3 2023

Nov 13, 2023

SELL
$5.2 - $8.77 $5 - $8
-1 Reduced 9.09%
10 $0
Q4 2022

Feb 13, 2023

SELL
$6.88 - $9.55 $6 - $9
-1 Reduced 8.33%
11 $0
Q3 2022

Nov 14, 2022

SELL
$8.19 - $13.2 $24 - $39
-3 Reduced 20.0%
12 $0
Q2 2022

Aug 10, 2022

SELL
$7.65 - $14.24 $30 - $56
-4 Reduced 21.05%
15 $0
Q1 2022

May 13, 2022

BUY
$13.02 - $20.78 $26 - $41
2 Added 11.76%
19 $0
Q4 2021

Feb 10, 2022

BUY
$19.35 - $25.54 $328 - $434
17 New
17 $0

Others Institutions Holding ALEC

About Alector, Inc.


  • Ticker ALEC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 82,563,904
  • Market Cap $212M
  • Description
  • Alector, Inc., a clinical stage biopharmaceutical company, develops therapies for the treatment of neurodegeneration diseases. Its products include AL001, a humanized recombinant monoclonal antibody, which is in Phase III clinical trial for the treatment of frontotemporal dementia, Alzheimer's, Parkinson's, and amyotrophic lateral sclerosis dise...
More about ALEC
Track This Portfolio

Track Covestor LTD Portfolio

Follow Covestor LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Covestor LTD, based on Form 13F filings with the SEC.

News

Stay updated on Covestor LTD with notifications on news.